NEUROENDOCRINE CARCINOMA
Clinical trials for NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug targets tough cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a radioactive drug called 177Lu-DTPA-SC16.56 in people with small-cell lung cancer or neuroendocrine prostate cancer that has worsened after standard chemotherapy. The main goal is to find the safest dose and see if the treatment can control the disea…
Matched conditions: NEUROENDOCRINE CARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for rare cancer: ZG006 faces chemo in phase 3 showdown
Disease control Not yet recruitingThis study tests a new drug called ZG006 against standard chemotherapy in 240 adults with advanced neuroendocrine carcinoma, a rare cancer. Participants must have a specific marker (DLL3) and have already tried at least one prior treatment. The main goal is to see if ZG006 helps …
Matched conditions: NEUROENDOCRINE CARCINOMA
Phase: PHASE3 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated May 20, 2026 11:57 UTC